Sage Capital Advisors,Llc Merck & Co., Inc. Transaction History

Sage Capital Advisors,Llc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 23, 2019	SELL	$69.58 - $79.36 $315,545 - $359,897	-4,535 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $480,753 - $557,906	-7,369 Reduced 61.9%	4,535 $346,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $30,979 - $36,430	-537 Reduced 4.32%	11,904 $844,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $76,956 - $90,416	1,514 Added 13.86%	12,441 $755,000
Q1 2018 May 01, 2018	BUY	$50.96 - $59.23 $662 - $769	13 Added 0.12%	10,927 $595,000
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $129,617 - $154,778	2,511 Added 29.88%	10,914 $614,000
Q3 2017 Nov 30, 2017	BUY	$58.67 - $63.13 $704 - $757	12 Added 0.14%	8,403 $538,000
Q2 2017 Aug 08, 2017	BUY	N/A	8,391	8,391 $538,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

Stay updated on Sage Capital Advisors,Llc with notifications on news.